Clinical Trial to Evaluate Repurposing Existing Medication as PD Treatment

Share

(October 10, 2014) - Researchers at the University of California, San Diego School of Medicine have launched a Phase III clinical trial to evaluate the drug isradipine, a calcium channel blocker often used to treat high blood pressure, as a potential new treatment for Parkinson disease (PD). The goal of the study is to determine whether the drug can slow the progression of the disease by keeping the brain’s dopamine-producing cells healthier for a longer period of time. Read more…

Click for a printer friendly version

Back to top